Immunomedics (MM)
   
To register click here

Immunomedics Stock Price IMMU

Company Description : A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. url: www.immunomedics.com

Name:
Immunomedics (MM)
Symbol:
NASDAQ:IMMU
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.08-2.912.672.626.52.852.582.7534910920:00:02
To register Click hereRegister for free Immunomedics stock prices.

BeaconEquity.com Issues TraderNotes on Active Stocks: CELI, UVSE, GSPG, GNTA, AAPL, IMMU, EXAS, EEE : DALLAS, July 15 /PRNewswire/ -- BeaconEquity.com announces the availability of a Technical Trade Alert for financial stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's...

Free Immunomedics Stock Charts

Immunomedics Historical Stock Chart
Immunomedics Historical Stock Chart
Immunomedics Monthly Stock Chart
Immunomedics Monthly Stock Chart
Immunomedics Intraday stock chart
Immunomedics Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Immunomedics stock Price, quotes, trades and FREE Immunomedics stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Immunomedics (IMMU) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Immunomedics News & Message Board Discussion

Latest Immunomedics News Headlines
DateTimeSource
Headline
07/15/20089:20AMPRNUSBeaconEquity.com Issues TraderNotes on Active Stocks: CELI, UVSE, GSPG, GNTA, AAPL, IMMU, EXAS, EEE
07/14/20089:36AMTFNFImmunomedics up in premarket on licensing pact with Nycomed
04/08/20081:16PMTFNFImmunomedics gets U.S. patent for use of anti-CD74 immunoconjugates
03/18/20089:01AMTFNFImmunomedics gets FDA orphan drug designation for milatuzumab
02/04/200812:56PMTFNFImmunomedics begins patient dosing in Phase I/II trial of veltuzumab
12/18/20073:49PMPRNUSPacira Pharmaceuticals Names David M. Stack CEO and President
12/10/20072:52PMTFNFImmunomedics says epratuzumab produced 'durable complete responses' in lymphoma
10/24/20071:39PMTFNFImmunomedics says milatuzumab shows promise in preclinical studies
Latest Message Board Discussions
DateTimeSource
TitleMore
11/15/20067:01PMFreeFDA gives OK to resume Lupus drug trials 

Immunomedics Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Immunomedics company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Immunomedics Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  400 2.7283 07/18/2008 4:11PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us nasdaq immu080720 07:30 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )